GSK's Rotavirus Vaccine Tied To Bowel Disorder

Law360, New York (June 16, 2011, 6:50 PM EDT) -- GlaxoSmithKline PLC's Rotarix has been linked to a serious bowel disorder in infants, but the benefits of the rotavirus vaccine far outweigh that risk, according to a study published Thursday in the New England Journal of Medicine.

The study tied the vaccine to a short-term risk of a bowel disorder called intussusception in one of every 51,000 to 68,000 vaccinated infants, researchers at the Centers for Disease Control and Prevention and a number of health agencies and hospitals in Brazil and Mexico revealed.

However, the number...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.